Guidance on using tocilizumab for juvenile idiopathic arthritis

Modern Rheumatology

Volumn 21, Issue 6, 2011, Pages 563-571

  Yokota, Shumpei ^a   Imagawa, Tomoyuki ^a   Takei, Syuji ^b   Murata, Takuji ^c   Tomiita, Minako ^d   Itoh, Yasuhiko ^e   Fujikawa, Satoshi ^f   Mori, Masaaki ^g  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Corticosteroid; Guidance; Juvenile idiopathic arthritis; Tocilizumab (anti IL 6 receptor antibody)

Indexed keywords

CORTICOSTEROID; CYTOKINE; CYTOKINE RECEPTOR; METHOTREXATE; TOCILIZUMAB;

BIOLOGICAL THERAPY; DRUG CHOICE; DRUG INDICATION; DRUG MECHANISM; DRUG WITHDRAWAL; HEALTH CARE PERSONNEL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; HUMANS;

EID: 84855705489     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0464-1     Document Type: Review

References (14)

1. Yokota S, Mori M, Imagawa T, Takei S, Murata T, Tomiita M, et al. Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007). Mod Rheumatol. 2007;17:353-63. (Pubitemid 47593481)
2. Yoshizaki K, Nakagawa T, Kaieda T, Muraguchi A, Yamamura Y, Kishimoto T. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol. 1982;128:1296-301. (Pubitemid 12188454)
3. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA. 1995;92:4862-6.
4. Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, et al. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study. J Rheumatol. 2003;30:1426-35. (Pubitemid 36835435)
5. Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000; 95:56-61. (Pubitemid 30017224)
6. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology. 2004;126:989-96. (Pubitemid 38451170)
7. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/ soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest. 1994;93:2114-9.
8. Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M, et al. Therapeutic efficacy of humanized recombinant anti-interleukin- 6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:818-25. (Pubitemid 40365104)
9. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safty of Tocilizumab in patients with systemiconset juvenile idiopathic arthritis: A randomized, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371: 998-1006. (Pubitemid 351389534)
10. Imagawa T, Yokota S, Mori M, Miyamae T, Takei S, Imanaka H, et al. Safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in patients with polyarticular course juvenile idiopathic arthritis. Mod Rheumatol; in press.
11. Stephan JL, Zeller J, Hubert PH, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases. Clin Exp Rheumatol. 1993;11:451-6. (Pubitemid 23287170)
12. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202-9. (Pubitemid 27430130)
13. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-8. 38.
14. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761-9. (Pubitemid 24371878)